NovoCure Limited - Ordinary Shares (NVCR) News

NovoCure Limited - Ordinary Shares (NVCR)

Today's Latest Price: $60.65 USD

1.04 (1.74%)

Updated Jul 2 4:00pm

Add NVCR to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 214 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

Filter NVCR News Items

NVCR News Results

Event/TimeSymbolCompanyNews DetailStartEndChangePOWR Rating
Loading, please wait...

Latest NVCR News From Around the Web

Below are the latest news stories about NovoCure Ltd that investors may wish to consider to help them evaluate NVCR as an investment opportunity.

Novocure to Report Second Quarter 2020 Financial Results

ST. HELIER, Jersey--(BUSINESS WIRE)---- $NVCR #earnings--Novocure will report financial results for the second quarter 2020 on Thursday, July 30, 2020, before the U.S. financial markets open.

Business Wire | July 1, 2020

Has NovoCure Limited (NASDAQ:NVCR) Stock's Recent Performance Got Anything to Do With Its Financial Health?

NovoCure's (NASDAQ:NVCR) stock up by 5.6% over the past three months. As most would know, long-term fundamentals have...

Yahoo | June 18, 2020

Hedge Funds Have Never Been This Bullish On NovoCure Limited (NVCR)

At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW). In these volatile markets we scrutinize hedge fund filings to get a reading on which direction each […]

Yahoo | June 8, 2020

Novocure launches MyLink tool in U.S.

Novocure (NVCR) has launched MyLink, a new tool that allows patients to download their Optune usage data from the comfort of home.Novocure initiated a phased launch with an initial wave of 30 U.S. patients to be followed by a broad rollout to all patients in the coming months. Optune is...

Seeking Alpha | June 2, 2020

Novocure Announces Launch of MyLink™ to Enable Patient-Guided, Remote Download of Optune® Usage Data

ST. HELIER, Jersey--(BUSINESS WIRE)--A new tool will enable patients to download their Optune usage data without the need for an in-person visit by a Novocure Device Support Specialist.

Business Wire | June 2, 2020

China NMPA Approves Optune® for the Treatment of Newly Diagnosed and Recurrent Glioblastoma

Novocure and Zai Lab announced that China NMPA approved Optune® for the treatment of newly diagnosed and recurrent glioblastoma.

Yahoo | May 13, 2020

Edited Transcript of NVCR earnings conference call or presentation 30-Apr-20 12:00pm GMT

Q1 2020 Novocure Ltd Earnings Call

Yahoo | May 6, 2020

Is NovoCure Limited (NASDAQ:NVCR) Potentially Undervalued?

NovoCure Limited (NASDAQ:NVCR), which is in the medical equipment business, and is based in Jersey, received a lot of...

Yahoo | May 4, 2020

NovoCure Limited (NVCR) Q1 2020 Earnings Call Transcript

On behalf of the entire NovoCure team, we would like to begin by wishing you well as we collectively face the challenges of the COVID-19 pandemic. Pritesh Shah, our Chief Commercial Officer; and Ely Benaim, our Chief Medical Officer, are also on the call and available for Q&A.

Yahoo | May 2, 2020

NovoCure (NVCR) Lags Q1 Earnings and Revenue Estimates

NovoCure (NVCR) delivered earnings and revenue surprises of -20.00% and -2.19%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research | April 30, 2020



Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.6399 seconds.